Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by Cranbury Pharmaceuticals, LLC, priced at $0.0599 per EA under NDC 27808026302. Its NADAC has been published 150 times since Aug 16, 2023.
Strength
250 mg/1
Manufacturer
Cranbury Pharmaceuticals, LLCNDC
27808026302
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA091491On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 150 times since Aug 16, 2023, and over the history we have for it it has declined 10.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0599 per EA |
|---|---|
| All-time high | $0.0740 (Dec 13, 2023) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0638 |
| 52-week low | $0.0562 |
| Median price | $0.0605 |
| Average price | $0.0604 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 150 |
| Tracking since | Aug 16, 2023 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Cranbury Pharmaceuticals, LLC, is $0.0599 per EA (NDC 27808026302), effective Jun 24, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 10.9%. It has been tracked across 150 weekly CMS publications since Aug 16, 2023.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Aug 16, 2023, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0740 (Dec 13, 2023), with a median of $0.0605 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 18% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 27808026302) is labeled by Cranbury Pharmaceuticals, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification